Subscribe to RSS
DOI: 10.1055/a-2811-7374
Design and Synthesis of Oligosaccharyltransferase Inhibitors: NGI-1 and Its Derivatives
Authors

Abstract
Despite its proven efficacy and excellent as an oligosaccharyltransferase inhibitor, the synthesis of NGI-1 (4) is poorly documented. In this study, we developed a robust synthetic protocol for NGI-1 and derivatives (4a–4j), featuring mild reaction conditions, scalability, and excellent yield and purity. Leveraging this methodology, we synthesized a series of derivatives (4a–4j) and subsequently evaluated their cytotoxicity against lung cancer cell lines A549. As a consequence, Compounds 4c, 4f, and 4j represent promising lead candidates, as their enhanced potency in suppressing cell viability outperforms that of the parent compound, NGI-1. Additionally, all compounds were unambiguously characterized by 1H NMR, 13C NMR, and MS.
Publication History
Received: 19 January 2026
Accepted after revision: 11 February 2026
Accepted Manuscript online:
11 February 2026
Article published online:
27 February 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Chan JF-W, Yuan S, Chu H, Sridhar S, Yuen K-Y. Nat Rev Microbiol 2024; 22 (07) 391-407
- 2 Jacob ST, Crozier I, Fischer WA. et al. Nat Rev Dis Primers 2020; 6 (01) 13
- 3 Cancer. World health organization. Feb 3, 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
- 4 Qiu B, Chen E, Flick T, Letarte S. MAbs. 2025 17. 01
- 5 Breitling J, Aebi M. Cold Spring Harb Perspect Biol 2013; 5: a013359
- 6 Cherepanova N, Shrimal S, Gilmore R. Curr Opin Cell Biol 2016; 41: 57-65
- 7 Pradeep P, Kang H, Lee B. Transl Psychiatry 2023; 13: 154
- 8 Watanabe Y, Bowden TA, Wilson IA, Crispin M. Biochim Biophys Acta Gen Subj 2019; 1863: 1480-1497
- 9 Pero JE, Mueller EA, Adams AM. et al. J Med Chem 2024; 67 (16) 14586-14608
- 10 Kelleher DJ, Karaoglu D, Mandon EC, Gilmore R. Mol Cell 2003; 12: 101-111
- 11 Rinis N, Golden JE, Marceau CD. et al. Cell Chem Biol 2018; 25 (10) 1231.e4-1241.e4
- 12 Lopez-Sambrooks C, Shrimal S, Khodier C. et al. Nat Chem Biol 2016; 12: 1023-1030
- 13 Harris D, Groß M, Staebler S, Ebert R, Seibel J, Boßerhoff AK. Cells. 2024 13. 22
- 14 Harada Y, Ohkawa Y, Kizuka Y, Taniguchi N. Int J Mol Sci 2019; 20 (23) 6074
- 15 Cheng J, Xia L, Hao X. et al. Cancer Res 2022; 11 (06) 1089-1107
- 16 WO2017019540A2.
- 17 WO2022051286A2.
- 18a Anderson GW, Zimmerman JE, Callahan FM. J Am Chem Soc 1963; 85: 3039
- 18b Anderson GW, Zimmerman JE, Callahan FM. J Am Chem Soc 1964; 86: 1839
- 19 Cline GW, Hanna SB. J Am Chem Soc 1987; 109: 3087
- 20a Ross PL, Huang YN, Marchese JN. et al. Mol Cell Proteomics 2004; 3: 1154
- 20b Abello N, Kerstjens HAM, Postma DS, Bischoff R. J Proteome Res 2007; 6: 4770
- 21 Asano S, Patterson JT, Gaj T, Barbas III CF. Angew Chem Int Ed 2014; 53: 11783
- 22a Pirrung MC, Biswas G, Ibarra-Rivera TR. Org Lett 2010; 12: 2402
- 22b Matiadis D, Igglessi-Markopoulou O. Eur J Org Chem 2010; 31: 5989
- 23 Gupta S, Das BC, Schafmeister CE. Org Lett 2005; 7: 2861
- 24a Jakobsche CE, Parker CG, Tao RN, Kolesnikova MD, Douglass Jr EF, Spiegel DA. ACS Chem Biol 2013; 8: 2404
- 24b Kim S, Lim C, Lee S. et al. ACS Comb Sci 2013; 15: 208
- 24c Niphakis MJ, Cognetta ABIII, Chang JW. et al. ACS Chem Neurosci 2013; 4: 1322
- 24d Park S, Pai J, Han E-H, Jun C-H, Shin I. Bioconjug Chem 2010; 21: 1246
- 25a Gembus V, Papamicaël C, Barré A, Ţînţaş M-L, Levacher V. Synthesis 2016; 49 (03) 472-483
- 25b Dunetz JR, Magano J, Weisenburger GA. Org Process Res Dev 2016; 20 (02) 140-177
- 26 Jou G, Gonzalez I, Albericio F, Lloyd-Williams P, Giralt E. J Org Chem 1997; 62: 354
- 27 Wang Q, Wang Y, Kurosu M. Org Lett 2012; 14 (13) 3372-3375